Apontis Pharma AG (APPH) — Defensive Interval Ratio
Apontis Pharma AG (APPH) has a Defensive Interval Ratio of 220 days as of June 2025. Defensive assets of €1.86 Million (cash €-, short-term investments €-, receivables €1.86 Million) cover 220 days of daily cash needs of €8.45K/day. Check Apontis Pharma AG tangible equity quality to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Apontis Pharma AG Defensive Interval Ratio (2018–2024)
This chart shows how Apontis Pharma AG's Defensive Interval Ratio has evolved across 7 annual periods from 2018 to 2024. As of June 2025, the ratio stands at 220 days, meaning defensive assets of €1.86 Million can fund 220 days of operations without new revenue. Also explore net asset growth rate of Apontis Pharma AG to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Apontis Pharma AG (2018–2024)
The table below presents the year-by-year Defensive Interval Ratio for Apontis Pharma AG from 2018 to 2024, covering 7 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see APPH company net worth.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 8 days | €108.07K | €13.02K/day | €- | €- | ▼ -10 days |
| 2023 | 18 days | €545.41K | €30.44K/day | €- | €-301.15K | ▼ -98 days |
| 2022 | 116 days | €1.89 Million | €16.33K/day | €- | €-490.42K | ▼ -168 days |
| 2021 | 284 days | €2.39 Million | €8.41K/day | €- | €-536.59K | ▲ +245 days |
| 2020 | 39 days | €1.95 Million | €50.20K/day | €- | €638.66K | ▲ +1 days |
| 2019 | 38 days | €1.75 Million | €46.12K/day | €- | €590.66K | ▼ -99 days |
| 2018 | 137 days | €6.76 Million | €49.25K/day | €- | €- | — |